Inhibitors

Items 1-10 of 4496

Page
per page
  1. VHL ligand 2 hydrochloride [orb611997]

    >98%

    [1948273-03-7]

    413.4

    C21H18F3N5O

    O=C (C1CC1)NC2=CC=CC (NC3=NC=CC (NC4=CC=CC (C (F) (F)F)=C4)=N3)=C2

    2 g, 1 g, 5 g
  2. Aurora Kinase Inhibitor III [orb611996]

    >98%

    [879127-16-9]

    413.4

    C21H18F3N5O

    O=C (C1CC1)NC2=CC=CC (NC3=NC=CC (NC4=CC=CC (C (F) (F)F)=C4)=N3)=C2

    250 mg, 1 g, 100 mg
  3. ZT-12-037-01 [orb611995]

    >98%

    [2328073-61-4]

    385.512

    C21H31N5O2

    COC1=CC2=NC (NC3CC3)=NC (NC4CCN (C (C)C)CC4)=C2C=C1OC

    250 mg, 1 g, 100 mg
  4. YW1159 [orb611994]

    >98%

    [2131223-69-1]

    347.3

    C19H14FN5O

    O=C (C1=C (C)N (C2=C (F)C=CC=C2)N=N1)NC3=CC=C (C=CC=C4)C4=N3

    250 mg, 1 g, 100 mg
  5. STING Agonist C11 [orb611993]

    >98%

    [875863-22-2]

    382.4

    C19H18N4O3S

    O=C (NC (NC)=O)C (SC1=NN=C (C2=CC=C (C)C=C2)O1)C3=CC=CC=C3

    250 mg, 1 g, 100 mg
  6. SR 16832 [orb611992]

    >98%

    [2088135-12-8]

    357.7

    C17H12ClN3O4

    COC1=CC=C2C (C (NC (C3=CC ([N+] ([O-])=O)=CC=C3Cl)=O)=CC=N2)=C1

    250 mg, 1 g, 100 mg
  7. Questiomycin A [orb611991]

    >98%

    [1916-59-2]

    212.2

    C12H8N2O2

    NC1=CC2=NC3=CC=CC=C3OC2=CC1=O

    250 mg, 1 g, 100 mg
  8. H-Gly-Arg-pNA (hydrochloride) [orb611990]

    >98%

    [125455-61-0]

    424.3

    C14H21N7O4.2HCl

    O=C ([C@@H] (NC (CN)=O)CCCNC (N)=N)NC1=CC=C ([N+] ([O-])=O)C=C1.Cl.Cl

    250 mg, 1 g, 100 mg
  9. Diprotin A [orb611989]

    >98%

    [90614-48-5]

    341.5

    C17H31N3O4

    O=C ([C@@H] (N)[C@@H] (C)CC)N1CCC[C@H]1C (N[C@H] (C (O)=O)[C@@H] (C)CC)=O

    250 mg, 1 g, 100 mg
  10. Cathepsin L inhibitor III [orb611988]

    >98%

    [114014-15-2]

    542.6

    C31H34N4O5

    O=C (N[C@@H] (CC1=CC=CC=C1)C (N[C@H] (C (C=[N+]=[N-])=O)CC2=CC=C (OC (C) (C)C)C=C2)=O)OCC3=CC=CC=C3

    250 mg, 1 g, 100 mg

Items 1-10 of 4496

Page
per page